Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ATRS

Antares Pharma (ATRS) Stock Price, News & Analysis

Antares Pharma logo

About Antares Pharma Stock (NASDAQ:ATRS)

Advanced Chart

Key Stats

Today's Range
$5.59
$5.59
50-Day Range
$5.59
$5.59
52-Week Range
$3.11
$5.60
Volume
6 shs
Average Volume
3.29 million shs
Market Capitalization
$955.06 million
P/E Ratio
23.29
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ATRS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Antares Pharma and its competitors with MarketBeat's FREE daily newsletter.

ATRS Stock News Headlines

Best Healthcare Penny Stocks
Antares Vision SpA AV
Trump’s New Order Could Boost Social Security Benefits by 400%
If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President Trump's Executive Order #14196 could not only save Social Security from collapse... ...but potentially increase benefits by up to 400%, according to legendary investor Louis Navellier.
Antares Vision Share Price (AV.MI)
Antares Reaches New 52-Week High (AIS)
Antares Vision SpA (ANV)
COP Syringes Market Competitive Situation By 2030
See More Headlines

ATRS Stock Analysis - Frequently Asked Questions

Antares Pharma, Inc. (NASDAQ:ATRS) posted its earnings results on Thursday, November, 4th. The specialty pharmaceutical company reported $0.03 earnings per share for the quarter, hitting the consensus estimate of $0.03. The specialty pharmaceutical company earned $48.19 million during the quarter, compared to the consensus estimate of $48.52 million. Antares Pharma had a net margin of 21.90% and a trailing twelve-month return on equity of 7.43%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Antares Pharma investors own include Ballard Power Systems (BLDP), Advanced Micro Devices (AMD), Novavax (NVAX), NVIDIA (NVDA), Micron Technology (MU), Meta Platforms (META) and Prospect Capital (PSEC).

Company Calendar

Last Earnings
11/04/2021
Today
7/03/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & Medical Instruments
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:ATRS
Employees
201
Year Founded
N/A

Profitability

Trailing P/E Ratio
23.29
Forward P/E Ratio
69.88
P/E Growth
N/A
Net Income
$46.29 million
Pretax Margin
29.84%

Debt

Sales & Book Value

Annual Sales
$183.98 million
Cash Flow
$0.13 per share
Price / Cash Flow
43.89
Book Value
$1.03 per share
Price / Book
5.43

Miscellaneous

Free Float
160,772,000
Market Cap
$955.06 million
Optionable
Optionable
Beta
1.15

Social Links

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

This page (NASDAQ:ATRS) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners